Viewing Study NCT00102050

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-05-19 @ 4:29 AM
Study NCT ID: NCT00102050
Status: COMPLETED
Last Update Posted: 2006-05-19
First Post: 2005-01-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication
Sponsor: Nissan Chemical Industries
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intermittent Claudication View
None Peripheral Vascular Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NM-702 tablets View
None intermittent claudication View
None peripheral View
None arterial View
None vascular View
None peripheral arterial disease View